Tanshinone IIA alleviates inflammation and apoptosis in myocardial ischemia-reperfusion injury by modulating the MALT1/NF-κB/NLRP3 signaling axis. | Synapse
April 16, 2026
Tanshinone IIA alleviates inflammation and apoptosis in myocardial ischemia-reperfusion injury by modulating the MALT1/NF-κB/NLRP3 signaling axis.
Key Points
This research aims to explore how tanshinone IIA affects inflammation and cell death in heart tissue during ischemia-reperfusion injury.
Assessment of myocardial inflammation and apoptosis levels
Modulation of the MALT1/NF-κB/NLRP3 signaling pathway
Evaluation of myocardial injury following intervention with tanshinone IIA
Tanshinone IIA significantly reduced markers of inflammation in myocardial tissue.
It decreased the rate of apoptosis in heart cells during ischemia-reperfusion.
The intervention effectively inhibited the activation of the MALT1/NF-κB/NLRP3 pathway.
Abstract
Tan IIA attenuated I/R-induced myocardial inflammation and apoptosis through the inhibition of the MALT1/NF-κB/NLRP3 signaling pathway, ultimately alleviating myocardial I/R injury.